Polypharmacy predominantly affects older adults due to the higher incidence of chronic conditions such as hypertension, diabetes, and cardiovascular diseases in this population. However, it is not limited to the elderly. Younger individuals with multiple chronic conditions or those undergoing complex treatments may also be subject to polypharmacy. Epidemiological studies often focus on these vulnerable populations to assess the prevalence and risks associated with multiple drug use.
